New Antibiotic Blujepa Approved for UTIs in 30 Years
Urinary tract infections (UTIs) are common among women, with up to 60% experiencing one during their lifetime. Post-menopausal women are particularly susceptible due to lower estrogen levels, which can lead to a decrease in beneficial bacteria that fight infection-causing bacteria. The US Food and Drug Administration (FDA) has approved Blujepa, the first new antibiotic for … Read more